MobileMedMinder: A Networked Aide for Medication Compliances

This study has been completed.
Sponsor:
Collaborator:
Limaging
Information provided by (Responsible Party):
Steve Gottlieb, University of Maryland
ClinicalTrials.gov Identifier:
NCT01597583
First received: May 10, 2012
Last updated: December 9, 2013
Last verified: December 2013
  Purpose

The main aim of this study is to conduct a randomized control trial to compare MobileMedMinder, a mobile phone based medication reminder software product, with currently accepted and empirically supported methods for increasing medication compliance through reminders and tracking.


Condition Intervention
Heart Failure, Congestive
Behavioral: Use of MobileMedMinder

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: MobileMedMinder: A Networked Aide for Medication Compliances

Resource links provided by NLM:


Further study details as provided by University of Maryland:

Primary Outcome Measures:
  • Compliance [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    Pill counts will be used to assess compliance


Estimated Enrollment: 50
Study Start Date: November 2011
Study Completion Date: December 2013
Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Use of MobileMedMinder Behavioral: Use of MobileMedMinder
Use of an intervention to remind patients to take their medications.
No Intervention: Usual care

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Taking beta blockers, ACE or ARB, and hydralazine for treatment of HF.

Exclusion Criteria:

  • Inability to understand informed consent
  • Inability to read and understand English
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01597583

Locations
United States, Maryland
University of Maryland
Baltimore, Maryland, United States, 21201
Sponsors and Collaborators
University of Maryland
Limaging
  More Information

No publications provided

Responsible Party: Steve Gottlieb, Professor, University of Maryland
ClinicalTrials.gov Identifier: NCT01597583     History of Changes
Other Study ID Numbers: HP-00051021
Study First Received: May 10, 2012
Last Updated: December 9, 2013
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on July 20, 2014